These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31035896)

  • 1. A Systematic Review of Health Outcomes Associated With Provision of Representative Payee Services.
    Kinsky SM; Creasy SL; Hawk M
    Psychiatr Serv; 2019 Aug; 70(8):714-727. PubMed ID: 31035896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case managers' and clients' perspectives on a representative payee program.
    Dixon L; Turner J; Krauss N; Scott J; McNary S
    Psychiatr Serv; 1999 Jun; 50(6):781-6. PubMed ID: 10375147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More Than a Means to an End: Alignment of Social Service Organizations' Missions with Representative Payee Program Goals.
    Olaniyan A; Creasy SL; Davis D; Merante M; Hawk M
    Community Ment Health J; 2021 Aug; 57(6):1073-1081. PubMed ID: 33595742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Support People the Way in Which They Want to Be Supported": Best Practices for Incorporating Client-Centeredness in Representative Payee Programs.
    Creasy SL; Olaniyan A; Davis D; Hawk M
    Community Ment Health J; 2021 Aug; 57(6):1065-1072. PubMed ID: 33128098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Representative payee programs for persons with mental illness in Illinois.
    Hanrahan P; Luchins DJ; Savage C; Patrick G; Roberts D; Conrad KJ
    Psychiatr Serv; 2002 Feb; 53(2):190-4. PubMed ID: 11821550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol of a randomized controlled trial to test the effects of client-centered Representative Payee Services on antiretroviral therapy adherence among marginalized people living with HIV.
    Olaniyan A; Creasy SL; Batey DS; Brooks MM; Maulsby C; Musgrove K; Hagan E; Martin D; Sashin C; Farmartino C; Hawk M
    BMC Public Health; 2020 Sep; 20(1):1443. PubMed ID: 32967646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial Capability: Clinicians' Assessment of Beneficiaries With Dual Diagnoses.
    Thornhill Iv TA; Black AC; Rosen MI
    J Dual Diagn; 2018; 14(2):130-136. PubMed ID: 29505348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Payeeship, financial leverage, and the client-provider relationship.
    Angell B; Martinez NI; Mahoney CA; Corrigan PW
    Psychiatr Serv; 2007 Mar; 58(3):365-72. PubMed ID: 17325110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An agency-based representative payee program and improved community tenure of persons with mental illness.
    Luchins DJ; Hanrahan P; Conrad KJ; Savage C; Matters MD; Shinderman M
    Psychiatr Serv; 1998 Sep; 49(9):1218-22. PubMed ID: 9735966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policy Implications of the Mental Health Treatment Study.
    Drake RE; Frey W; Karakus M; Salkever D; Bond GR; Goldman HH
    Psychiatr Serv; 2016 Oct; 67(10):1139-1141. PubMed ID: 27247172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of representative payee services on medication adherence among unstably housed people living with HIV/AIDS.
    Hawk M; McLaughlin J; Farmartino C; King M; Davis D
    AIDS Care; 2016; 28(3):384-9. PubMed ID: 26444847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does assigning a representative payee reduce substance abuse?
    Rosen MI; McMahon TJ; Rosenheck R
    Drug Alcohol Depend; 2007 Jan; 86(2-3):115-22. PubMed ID: 16839710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of representative payees on substance use by homeless persons with serious mental illness.
    Rosenheck R; Lam J; Randolph F
    Psychiatr Serv; 1997 Jun; 48(6):800-6. PubMed ID: 9175189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of psychiatric care with representative payeeship for persons with serious mental illness.
    Conrad KJ; Lutz G; Matters MD; Donner L; Clark E; Lynch P
    Psychiatr Serv; 2006 Feb; 57(2):197-204. PubMed ID: 16452696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating Harm Reduction Principles in a Client-Centered Representative Payee Program.
    Abua J; Hagert Z; Baumann S; Batey S; Creasy S; Davis D; Kay E; Hawk M
    Community Ment Health J; 2024 Feb; 60(2):366-375. PubMed ID: 37682381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use and assignment of representative payees.
    Rosen MI; Rosenheck R
    Psychiatr Serv; 1999 Jan; 50(1):95-8. PubMed ID: 9890587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric disorder and unmet service needs among welfare clients in a representative payee program.
    Evans JD; Wright DE; Svanum S; Bond GR
    Community Ment Health J; 2004 Dec; 40(6):539-48. PubMed ID: 15672692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer views of representative payee use of disability funds to leverage treatment adherence.
    Elbogen EB; Soriano C; Van Dorn R; Swartz MS; Swanson JW
    Psychiatr Serv; 2005 Jan; 56(1):45-9. PubMed ID: 15637191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing disability benefits as part of treatment for persons with severe mental illness and comorbid drug/alcohol disorders. A comparative study of payee and non-payee participants.
    Ries RK; Comtois KA
    Am J Addict; 1997; 6(4):330-8. PubMed ID: 9398931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Representative payee practices of community mental health centers in Washington State.
    Ries RK; Dyck DG
    Psychiatr Serv; 1997 Jun; 48(6):811-4. PubMed ID: 9175191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.